INTREPID

INTREPID project aims at developing a multi-sensor wearable system for the treatment of phobias and situational anxiety. INTREPID project actively contributes to the treatment of phobias in an unobtrusive, personalized and intelligent manner.

INTREPID will serve to empower Community citizens in the management of their individual health, to provide health care professionals and facilities with a reliable phobias treatment and decision support tool and to create new opportunities for the medical wearable device industry. INTREPID will build upon the well documented increasing demand for "healthy lifestyle" products and services on the consumer side and offer potentially significant returns for those who chose to invest in the project outcome.

The INTREPID project scientific objectives are:

  • To effectively exploit the synergy in the information acquired from the various biometric sensors and develop new and efficient data fusion techniques, which will significantly broaden machine perception and enhance awareness of the phobia's states.
  • To create an identification system of the physiological and phobia-based emotional state of a patient (phobia's state) that will be based on the association of the information coming from the various biometric sensors.
  • To create a decision-making system that will project the current patient's phobia state into the future and draw inferences about the actions that should be taken in order to keep the patient in the desired phobia's state.
  • To create a new centralised sensor management system that will use active and selective perception techniques in order to optimize the overall performance of the identification system and the tracking system.
  • To create a powerful, intelligent and innovative humancomputer interaction environment that will boost the research and work on affective wearable computing and machine emotional intelligence domain.

The INTREPID project technological objectives are:

  • To create an advanced tracking system that will optimally monitor the symptoms of phobias. The system will measure heart rate, perspiration rate, breath rate, muscle stiffness and if needed complementary modalities through a set of miniaturized wearable sensors that the patient wears during the treatment session.
  • To create a sophisticated environment in a commercial wearable computer that will consist of:
  • To create a professional site for psychologists and therapists that will assist them to design the next steps of the patient's therapy taking into account the individualized physiological and emotional state of each patient.

For further information, please visit:
http://www.intrepid-project.org

Project co-ordinator:
Manchester University (UK)

Partners:

  • UNIMAN (UK)
  • ESIEA (FR)
  • AURELIA MICRO (IT)
  • UoI (EL)
  • PALADION (EL)
  • Elyros (BE)
  • InFocus (UK)

Timetable: from 01/04 to 12/06

Total cost: € 3,228,334

EC funding: € 2,000,000

Instrument: STREP

Project Identifier: IST-2002-507464

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...